Important data using ResistancePlus® MG to investigate over 1500 symptomatic vaginitis patients. Mycoplasma genitalium (Mgen) infection was more prevalent in women with bacterial vaginosis (BV) (7.0% Mgen positive) compared with...
SpeeDx is committed to continually improving and innovating diagnostics with ongoing advances spun out of our remarkable Blue Sky Research team. Our scientists are investigating an isothermal, protein-enzyme-free approach to...
SpeeDx today announced it has raised $15 million in additional series B equity investment from U.S.-based Northpond Ventures. This investment comes with a company value uptick of 21.22%. "SpeeDx's molecular diagnostic...
SpeeDx and LabCorp are working together to develop and introduce new tests with the promise to help improve patient care, focusing on women’s health and infectious diseases. "We are excited about...